| Literature DB >> 28678182 |
Ying Yin1,2, Qiang Fu3, Wenhui Wu4, Menghao Cai5, Xiangshan Zhou6, Yuanxing Zhang7,8.
Abstract
Many fungi in the Stachybotrys genus canEntities:
Keywords: Stachybotrys; amino compound; fibrinolytic activity; genome mining; isoindolinone biosynthesis
Mesh:
Substances:
Year: 2017 PMID: 28678182 PMCID: PMC5532656 DOI: 10.3390/md15070214
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The structures of FGFCs and SMTP-7.
Predicted gene cluster responsible for isoindolinone biosynthesis in Stachybotrys. The gene cluster in S. chlorohalonata IBT 40285 was compared to its homologues in S. chartarum IBT 7711 and S. bisbyi PYH05-7.
| Gene | Locus Tag | Protein Identity (%) | Protein Identity (%) | Putative Function | ||
|---|---|---|---|---|---|---|
|
| S40285_07604 | S7711_05923 | 98 | Transcriptional regulator | ||
|
| S40285_07605 | S7711_05924 | 78 (34% coverage) | Nitrate reductase (partial in | ||
| S7711_05925 | Carboxylesterase | |||||
|
| S40285_07606 | S7711_05926 | 97 | Esterase | ||
|
| S40285_07607 | S7711_05927 | 100 | Short-chain dehydrogenase | ||
|
| S40285_07608 | S7711_05928 | 94 | Isomerase/epimerase | ||
|
| S40285_07609 | S7711_05929 | 97 | Copper dependent oxidase | ||
|
| S40285_07610 | S7711_05930 | 96 | Short-chain dehydrogenase | ||
|
| S40285_10521 | S7711_10996 | 98 |
| 76 | PT |
|
| S40285_07611 | S7711_05931 | 98 |
| 73 | NRPS-like |
|
| S40285_07612 | S7711_05932 | 98 |
| 75 | NR-PKS |
Figure 2Proposed gene cluster and biosynthesis processes of isoindolinone derivatives in Stachybotrys. (A) Predicted gene cluster responsible for isoindolinone biosynthesis in S. chlorohalonata IBT 40285. (B) Proposed biosynthesis processes of isoindolinone derivatives in Stachybotrys. The three steps catalyzed by the three core genes are shown in an orange block.
Figure 3HPLC assay of S. longispora FG216 metabolites with different amino compounds supply. ((a) 3-amino-2-piperidinone, (b) (3S)-3-amino-2-piperidinone hydrochloride, (c) glycine, (d) l-threonine, and (e) no supply control.)
1H (400 MHz) and 13C NMR (100 MHz) data for new FGFC congeners (in MeOH-d4, J in Hz).
| FGFC4 | FGFC5 | FGFC6 | FGFC7 | |||||
|---|---|---|---|---|---|---|---|---|
|
| δC | δH | δC | δH | δC | δH | δC | δH |
| 2 | 171.6, C | 171.5, C | 171.7, C | 172.6, C | ||||
| 3 | 132.4, C | 132.4, C | 132.2, C | 131.7, C | ||||
| 4 | 100.9, CH | 6.77 s | 101.0, CH | 6.77 s | 101.1, CH | 6.78 s | 101.0, CH | 6.80 s |
| 5 | 158.0, C | 158.2, C | 158.0, C | 157.8, C | ||||
| 6 | 113.5, C | 113.6, C | 113.6, C | 113.6, C | ||||
| 7 | 27.7, CH2 | 3.00 dd (17.6, 5.4) | 27.8, CH2 | 3.01 dd (17.7, 5.5) | 27.8, CH2 | 3.00 dd (17.7, 5.4) | 27.8, CH2 | 3.01 dd (17.7, 5.3) |
| 2.67 dd (17.6, 7.1) | 2.66 dd (17.7, 7.4) | 2.68 dd (17.7, 7.0) | 2.70 dd (17.7, 6.8) | |||||
| 8 | 68.3, CH | 3.90 dd (7.0, 5.6) | 68.5, CH | 3.89 dd (7.2, 5.7) | 68.4, CH | 3.90 t (6.2) | 68.4, CH | 3.91 t (6.0) |
| 9 | 80.2, C | 80.2, C | 80.3, C | 80.2, C | ||||
| 11 | 150.0, C | 150.0, C | 150.0, C | 150.0, C | ||||
| 12 | 121.9, C | 121.9, C | 122.2, C | 123.1, C | ||||
| 13 | 46.8, CH2 | 4.36 d (16.7) | 46.9, CH2 | 4.34 d (16.7) | 49.6, CH2 | 4.39 s | 48.6, CH2 | 4.65 m |
| 4.24 d (16.7) | 4.25 d (16.7) | |||||||
| 14 | 38.6, CH2 | 1.69 m | 38.6, CH2 | 1.71 m | 38.6, CH2 | 1.69 m | 38.5, CH2 | 1.70 m |
| 15 | 22.6, CH2 | 2.20 m | 22.6, CH2 | 2.21 m | 22.6, CH2 | 2.20 m | 22.6, CH2 | 2.19 m |
| 16 | 125.5, CH | 5.16 t (6.8) | 125.6, CH | 5.17 t (6.7) | 125.5, CH | 5.16 t (6.9) | 125.4, CH | 5.16 t (6.9) |
| 17 | 136.3, C | 136.2, C | 136.3, C | 136.3, C | ||||
| 18 | 40.8, CH2 | 1.99 m | 40.9, CH2 | 1.99 m | 40.8, CH2 | 1.98 m | 40.8, CH2 | 1.97 m |
| 19 | 27.7, CH2 | 2.07 m | 27.7, CH2 | 2.07 m | 27.7, CH2 | 2.07 m | 27.7, CH2 | 2.07 m |
| 20 | 125.4, CH | 5.10 t (7.0) | 125.4, CH | 5.09 t (6.9) | 125.4, CH | 5.08 t (6.9) | 125.4, CH | 5.07 t (6.9) |
| 21 | 132.2, C | 132.2, C | 132.2, C | 132.2, C | ||||
| 22 | 25.9, CH3 | 1.67 s | 25.9, CH3 | 1.67 s | 25.9, CH3 | 1.66 s | 25.9, CH3 | 1.65 s |
| 23 | 17.8, CH3 | 1.59 s | 17.8, CH3 | 1.59 s | 17.8, CH3 | 1.58 s | 17.8, CH3 | 1.57 s |
| 24 | 16.0, CH3 | 1.60 s | 16.0, CH3 | 1.61 s | 16.0, CH3 | 1.60 s | 16.0, CH3 | 1.58 s |
| 25 | 18.8, CH3 | 1.29 s | 18.6, CH3 | 1.28 s | 18.8, CH3 | 1.30 s | 19.0, CH3 | 1.31 s |
| 1’ | 171.7, C | 171.8, C | 171.7, C | 173.0, C | ||||
| 2’ | 53.6, CH | 4.80 dd (10.6, 7.1) | 53.6, CH | 4.78 dd (10.6, 6.9) | 45.0, CH2 | 4.34 s | 61.4, CH | 4.89 d (3.8) |
| 3’ | 27.3, CH2 | 2.13 m | 27.3, CH2 | 2.14 m | 68.2, CH | 4.62 m | ||
| 4’ | 22.9, CH2 | 2.03 m | 22.9, CH2 | 2.03 m | 20.7, CH3 | 1.20 d (6.3) | ||
| 5’ | 43.0, CH2 | 3.37 brs | 43.0, CH2 | 3.37 brs | ||||
Figure 4The HMBC correlation data of FGFC4–FGFC7.
Figure 5The relative activities of FGFC6 and FGFC7 in different concentrations. (Extra 30 nmol/L pro-uPA and 0.1 g/L FGFC1 were set as positive controls, respectively. The relative activity of no supply negative control was set as 1.)